Analyst Ratings for Cadence Pharma (CADX) [Neutrals]
CADX Rating Summary
CADX Price Target Summary
- Highest: $12.00 (Duncan Williams)
- Lowest: $3.00 (UBS)
- Average: $6.94
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.94 (-3.4%)
Avg. $ Target:
$6.94 (-3.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/30/2012 | Leerink Swann | Downgrade | Market Perform (Outperform) |
4.50 (5.00) |
4.42 | 7.18 | 62.44% | Details |
| 11/17/2011 | Oppenheimer » Updated 8/3/2012 |
Upgrade | Perform (N/A) |
N/A (N/A) |
3.79 | 7.18 | 89.45% | Details |
| 12/16/2010 | UBS » Updated 6/18/2012 |
New Coverage | Neutral (N/A) |
3.00 (4.00) |
7.86 | 7.18 | -8.65% | Details |
